# How Long Ipamorelin Stays in Your System: Half-Life

> How long does ipamorelin stay in your system? Its terminal half-life is about 2 hours in humans, the GH pulse peaks near 40 minutes, and anti-doping labs can still detect it — here's the detail.

About two hours in people — but "how long it acts," "how long it lingers," and "how long it's detectable" are three different questions.

## The short version

Asking **how long does ipamorelin stay in your system** is really asking three questions, so let's separate them. One: how long does it *act*? The growth hormone pulse it triggers peaks around 40 minutes after dosing and is a single discrete burst [2]. Two: how long does the *molecule itself* linger? Its terminal half-life in humans is about 2 hours, meaning it's mostly cleared within roughly half a day [2]. Three: how long is it *detectable*? That's a different clock — anti-doping labs have validated urine tests for growth-hormone secretagogues like ipamorelin, and "cleared from the blood" does not mean "undetectable" [11]. This page walks all three, with the one well-characterized number — the 2-hour half-life — front and center, because unlike most ipamorelin facts, this one rests on a clean human study [2].

## The half-life number, and where it comes from

The headline figure: in healthy human volunteers, ipamorelin's terminal half-life (the time for blood levels to fall by half during elimination) is approximately 2 hours [2]. That comes from a 1999 population PK/PD study giving eight men per dose level single 15-minute IV infusions across five dose levels [2]. The same study pinned clearance at 0.078 L/h/kg and a steady-state volume of distribution of 0.22 L/kg, with dose-proportional (linear) kinetics — double the dose, double the exposure, no surprises [2]. As a rule of thumb, a compound is largely eliminated after about four to five half-lives, which puts ipamorelin in the rough neighborhood of 8 to 10 hours to clear the bloodstream [2]. This is genuinely the most solid number in the entire ipamorelin literature.

## How long it acts vs how long it lingers

These two are easy to conflate. The *effect* — the GH pulse — is fast and brief: it peaks around 40 minutes (0.67 h) post-dose as a single discrete pulse, then subsides [2]. The *drug* takes a bit longer to clear, on that ~2-hour half-life [2]. So the window where ipamorelin is meaningfully driving GH release is short and front-loaded, while trace amounts of the peptide hang around somewhat longer as it's eliminated [2]. For comparison, in rats ipamorelin's plasma clearance is roughly five-fold lower than the older peptide GHRP-6, so species and formulation matter [1]. An ipamorelin-derived oral analog, NN703, was engineered to a longer 4.1-hour half-life in dogs — but that's a different molecule, not ipamorelin [7].

## Detection is a separate clock

If the reason you're asking is sport, the half-life is not the number that matters. Ipamorelin and other growth-hormone secretagogues are prohibited in sport at all times under the WADA Prohibited List category S2, and accredited anti-doping laboratories have established urine-detection methods for this class [11]. "Cleared from the blood on a 2-hour half-life" tells you nothing about how long a test can flag it — detection windows for peptide secretagogues are governed by assay sensitivity and metabolite persistence, not by the parent drug's plasma half-life [11]. The honest summary: a 2026 sports-medicine review classified ipamorelin as an investigational, prohibited GH-axis secretagogue with established detection [11], so anyone subject to testing should treat "undetectable" as not assumable from the half-life alone.

## What changes the timeline

A few factors shift these numbers. Route matters: the human half-life figure is from intravenous dosing [2], while the subcutaneous route common in community use creates a slower absorption phase that effectively extends the time the peptide is present (though it has no published human PK characterization) [2]. Metabolic state matters too: in diabetic mice, IV ipamorelin produced exaggerated GH hypersecretion (150 ± 35 µg/L vs 62 ± 11 µg/L in controls) alongside hepatic GH-receptor resistance, showing the *response* to a given exposure can change even when the kinetics don't [8]. And formulation matters — engineered analogs were deliberately built for longer half-lives and oral availability, at the cost of some of ipamorelin's hormonal selectivity [7].

## The bottom line on timing

To close the loop on how long ipamorelin stays in your system: the molecule's terminal half-life is about 2 hours in humans [2], the GH pulse it triggers peaks near 40 minutes and is brief [2], rough full blood clearance lands in the 8–10 hour range [2], and detectability for anti-doping purposes is a separate, longer, assay-dependent question [11]. That 2-hour half-life is the one ipamorelin number you can quote with real confidence, because it's backed by a clean human PK study [2]. For the puffiness-and-fluid companion question, see [does ipamorelin cause water retention](/water-retention); for everything reported and every caution, the [Ipamorelin effects](/effects) page has it.

---

A bright, safety-first reading of the ipamorelin record — the clean cortisol-sparing GH pulse credited as the design win it is, the lone failed human trial and the empty long-term-safety shelf kept in plain sight, and the community reports pinned to one side as anecdote; no clinic behind the page, no prescription written despite the name, and nothing here dosed, supplied, or sold.
